Pegvorhyaluronidase alfa
Pegvorhyaluronidase alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).
| Trade Name | Pegvorhyaluronidase alfa |
| Generic | Pegvorhyaluronidase alfa |
| Pegvorhyaluronidase alfa Other Names | Pegvorhyaluronidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pegvorhyaluronidase alfa
